journal article·2009-04-15

NIR-to-visible upconversion nanoparticles for fluorescent labeling and targeted delivery of siRNA

Shan Jiang, Yong Zhang, Kian Meng Lim, Eugene K W Sim, Lei Ye

Nanotechnology· Volume 20· Issue 15
Publisher page

Abstract

Near-infrared (NIR)-to-visible upconversion fluorescent nanoparticles were synthesized and used for imaging and targeted delivery of small interfering RNA (siRNA) to cancer cells. Silica-coated NaYF(4) upconversion nanoparticles (UCNs) co-doped with lanthanide ions (Yb/Er) were synthesized. Folic acid and anti-Her2 antibody conjugated UCNs were used to fluorescently label the folate receptors of HT-29 cells and Her2 receptors of SK-BR-3 cells, respectively. The intracellular uptake of the folic acid and antibody conjugated UCNs was visualized using a confocal fluorescence microscope equipped with an NIR laser. siRNA was attached to anti-Her2 antibody conjugated UCNs and the delivery of these nanoparticles to SK-BR-3 cells was studied. Meanwhile, a luciferase assay was established to confirm the gene silencing effect of siRNA. Upconversion nanoparticles can serve as a fluorescent probe and delivery system for simultaneous imaging and delivery of biological molecules.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (32)

Show source-provided references
1. 10.1073/pnas.070242710410.1073/pnas.0702427104 ↗
2. 10.1016/j.addr.2006.07.00410.1016/j.addr.2006.07.004 ↗
3. 10.1016/j.cbpa.2003.08.00710.1016/j.cbpa.2003.08.007 ↗
4. 10.1021/nl062962v10.1021/nl062962v ↗
5. 10.1021/nl063031m10.1021/nl063031m ↗
6. 10.1007/s10895-007-0163-710.1007/s10895-007-0163-7 ↗
7. 10.1073/pnas.050489210210.1073/pnas.0504892102 ↗
8. Corstjens P · Clin. Chem. · 2001 · 47 · 188510.1093/clinchem/47.10.1885 ↗
9. 10.1016/S0009-9120(03)00057-210.1016/S0009-9120(03)00057-2 ↗
10. 10.1006/abio.2000.490210.1006/abio.2000.4902 ↗
11. 10.1006/abio.1998.296510.1006/abio.1998.2965 ↗
12. 10.1021/nl051917510.1021/nl0519175 ↗
13. 10.1038/8573410.1038/85734 ↗
14. 10.1021/cm031124o10.1021/cm031124o ↗
15. 10.1016/j.biomaterials.2007.10.05110.1016/j.biomaterials.2007.10.051 ↗
16. 10.1016/j.biomaterials.2008.07.01210.1016/j.biomaterials.2008.07.012 ↗
17. 10.1038/3588810.1038/35888 ↗
18. 10.1038/3507810710.1038/35078107 ↗
19. 10.1593/neo.0431310.1593/neo.04313 ↗
20. 10.1016/j.bbrc.2005.02.02410.1016/j.bbrc.2005.02.024 ↗
21. 10.1038/nature0312110.1038/nature03121 ↗
22. 10.1038/nature0468810.1038/nature04688 ↗
23. 10.1038/418038a10.1038/418038a ↗
24. 10.1016/j.cbpa.2004.10.00710.1016/j.cbpa.2004.10.007 ↗
25. 10.1093/nar/gnh14010.1093/nar/gnh140 ↗
26. 10.1101/gr.157500310.1101/gr.1575003 ↗
27. 10.1093/nar/gni18810.1093/nar/gni188 ↗
28. 10.1016/j.biomaterials.2006.11.01810.1016/j.biomaterials.2006.11.018 ↗
29. 10.1021/ja034450d10.1021/ja034450d ↗
30. 10.1021/bc000063710.1021/bc0000637 ↗
31. 10.1073/pnas.050492610210.1073/pnas.0504926102 ↗
32. Li Z Q · Adv. Mater. · 2008 · 20 · 110.1002/adma.200890067 ↗